Stock Movers

On this episode of Stock Movers:
- Micron (MU) shares rise after a KeyBanc analyst John Vinh repeated an Overweight rating. This comes as Micron Technology Inc. is facing challenges in the stock market, with its shares down nearly 20% since hitting a high three weeks ago due to concerns about the memory sector and uncertainty in the broader market.
- Dow (DOW US) shares drop. US chemical stocks are lower on Monday as oil prices pull back and BofA downgrades the stocks as it sees the market tailwinds from the Iran war as unsustainable.
- Carvana (CVNA) shares fall. BofA Global Research downgraded the online used-car retailer to neutral from buy citing recent macro and industry developments.
See omnystudio.com/listener for privacy information.

On this episode of Stock Movers:
- Carvana shares (CVNA) falls. BofA Global Research downgrades the online used-car retailer to neutral from buy citing recent macro and industry developments. Analyst Michael McGovern says with “the recent oil shock potentially pressuring an already stretched lower & middle income consumer, and 2-year rates moving the opposite direction, we think the risk/reward profile is more balanced now.”
- Netflix shares (NFLX) are up after Goldman Sachs upgraded the streaming-video company to buy from neutral. “We expect NFLX’s upcoming earnings report to reflect a strong start to 2026 as management continues to execute well against its core areas of strategic focus,” writes analyst Eric Sheridan.
- Tyson Foods shares (TSN) rise as Piper Sandler upgrades to overweight from neutral citing potential near-term catalysts in beef and chicken. Analyst Michael Lavery says Tyson “has strong top-line momentum with its portfolio benefitting from consumer shifts to more protein.”
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:
- Gulf Funds Agree to Back Paramount's $81 Billion Takeover of Warner
- Netflix (NFLX) shares are up after Goldman Sachs upgraded the streaming-video company to buy from neutral.
- Neurocrine Biosciences agreed to buy Soleno Therapeutics for $2.9 billion to expand in rare genetic disorders. The biotechnology company will pay $53 per share for Soleno, a 34% premium to its closing share price Thursday, using cash on hand and some pre-payable debt. Both company boards have approved the transaction, which is expected to close within 90 days.
See omnystudio.com/listener for privacy information.

Today's biggest winners and losers in the stock market.

On this episode of Stock Movers:

- Soleno Therapeutics (SLNO) shares gain as much as 32% in premarket trading on Monday after the Financial Times reports that Neurocrine is in advanced talks to buy the company in a deal that could value it in the low-to-mid $50s per share, or in the excess of $2.5 billion.
- Tyson Foods (TSN) shares rise 1.8% premarket as Piper Sandler upgrades to overweight from neutral citing potential near-term catalysts in beef and chicken.
- Applied Optoelectronics (AAOI) received a new $71 million order for 800G single-mode data center transceivers from a hyperscale customer.
See omnystudio.com/listener for privacy information.

Earnings are still in focus with Constellation Brands, Levi Strauss, and Delta Airlines all reporting in the coming days.
Bloomberg's Nathan Hager previews the numbers with Tatiana Darie, Bloomberg Strategist for Markets Live.
See omnystudio.com/listener for privacy information.